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Bacterial secondary transporters of the DctA family mediate ion-coupled uptake of C4-dicarboxylates. Here,
we have expressed the DctA homologue from Bacillus subtilis in the Gram-positive bacterium Lactococcus lactis.
Transport of dicarboxylates in vitro in isolated membrane vesicles was assayed. We determined the substrate
specificity, the type of cotransported ions, the electrogenic nature of transport, and the pH and temperature
dependence patterns. DctA was found to catalyze proton-coupled symport of the four C4-dicarboxylates from
the Krebs cycle (succinate, fumurate, malate, and oxaloacetate) but not of other mono- and dicarboxylates.
Because (i) succinate-proton symport was electrogenic (stimulated by an internal negative membrane poten-
tial) and (ii) the divalent anionic form of succinate was recognized by DctA, at least three protons must be
cotransported with succinate. The results were interpreted in the light of the crystal structure of the homol-
ogous aspartate transporter GltPh from Pyrococcus horikoshii.
The DctA family is one of several diverse families of sec-
ondary transporters that catalyze the uptake of C4-dicarboxy-
lates from the Krebs cycle in bacteria (16, 27). In Escherichia
coli, DctA mediates the uptake of succinate, fumurate, and
malate under aerobic conditions; genomic disruption of dctA in
E. coli prevents growth with malate or fumarate as the sole
carbon source, and the mutant grows poorly on succinate (5).
Similarly, a dctA knockout mutant of Bacillus subtilis cannot
grow with succinate or fumarate as the sole carbon source (1).
DctA plays a major role in the symbiotic relationship between
nitrogen-fixing rhizobia (43) and root nodule-forming plants
(30, 37, 38). Transport assays with Sinorhizobium meliloti cells
showed previously that in addition to succinate, malate, and
fumarate, orotate is transported and that a range of other
substrates such as succinamic acid and succinamide may be
transported, because they inhibit the transport of orotate (42).
In Corynebacterium glutamicum, malate transport by DctA is
inhibited by a-ketoglutarate, oxaloacetate, and glyoxylate, in-
dicating that these compounds may be substrates also (41).
DctA transporters belong to a large family of secondary
transporters (the DAACS [dicarboxylate/amino acid:cation
symporter] family), which also comprises well-characterized
glutamate/aspartate transporters and neutral amino acid trans-
porters (32, 33). While DctA-type dicarboxylate transporters
are found only in bacteria, glutamate/aspartate transporters of
the DAACS family are found both in prokaryotes (e.g., GltT in
Bacillus stearothermophilus, GltP in E. coli, and GltPh in Pyro-
coccus horikoshii [2, 7, 34]) and in higher eukarya, where they
play a pivotal role in the reuptake of the excitatory neurotrans-
mitter glutamate from the synaptic cleft (4). Neutral amino
acid (alanine, serine, and threonine) transporters are found in
mammals (see, e.g., references 36 and 44) as well as bacteria
(17).
Secondary transporters of the DAACS family use (electro)
chemical gradients of cations across the membrane to drive
transport. The type of cotransported ions varies among family
members: eukaryotic glutamate transporters couple the trans-
port of glutamate to the symport of one proton and three
sodium ions and the antiport of one potassium ion (24, 45).
Bacterial and archaeal glutamate transporters utilize either
sodium ions or protons for symport (2) and are independent of
potassium ions (28, 31). The bacterial and mammalian neutral
amino acid transporters are sodium ion coupled. Glutamate/
aspartate transporters and bacterial serine/threonine trans-
porters (SstTs) are electrogenic, but mammalian neutral amino
acid transporters are obligate electroneutral amino acid anti-
porters (44).
Insight into the structure-function relationships of the
DAACS family members has greatly increased since crystal
structures of the P. horikoshii aspartate transporter GltPh have
been determined (2, 29, 40). The protein consists of eight
membrane-spanning helices and two reentrant regions (helical
hairpins HP1 and HP2) (40). The C-terminal part of the pro-
tein (helices 7 and 8 and HP1 and HP2) is most strongly
conserved with respect to other family members and binds the
substrate and cotransported ions, with HP1 and HP2 function-
ing as lids that allow alternating access to the substrate- and
ion-binding sites from either side of the membrane (3, 29).
GltPh forms a homotrimeric complex in which each protomer
functions independently of the other subunits (11, 12, 18, 19,
23). The fold and oligomeric state are likely to be conserved
throughout the family.
Whereas the transport mechanisms of bacterial glutamate
and neutral amino acid transporters of the DAACS family
have been studied extensively in vitro, the C4-dicarboxylate
transporters of the DAACS family (DctA proteins) have been
studied using whole cells only. To fully characterize these
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transporters, in vitro activity assays using either membrane
vesicles or proteoliposomes containing purified protein are
necessary. In such assays, the internal and external buffer com-
positions can be controlled, thus allowing manipulation of the
chemical ion gradients and the electrical potential across the
membrane. Here, we present the first biochemical character-
ization of a DctA family member in membrane vesicles. We
have studied the DctA homologue from B. subtilis, which is
annotated as DctP (1) but which we propose to rename DctA
to reflect the homology to other DctA proteins. B. subtilis
DctA (DctABs) has 30 to 32% sequence identity to the aspar-
tate transporter GltPh and human excitatory amino acid trans-
porter (EAAT) family members, over 40% sequence identity
to the characterized bacterial glutamate transporters from E.
coli and B. stearothermophilus, and 41 and 56% identity to
DctA homologues from C. glutamicum and E. coli, respec-
tively. We determined the substrate specificity of DctABs, the
type of cotransported ions, the electrogenic nature of trans-
port, and the pH and temperature dependence patterns.
MATERIALS AND METHODS
Chemicals. Restriction enzymes and polymerases were purchased from Fer-
mentas Life Sciences (Burlington, CA). [14C]succinate (1.85 MBq/ml [2.04 GBq/
mmol]) was purchased from ARC Radiochemicals (St. Louis, MO). Lipids were
purchased from Avanti Polar Lipids (Alabaster, AL). All chemicals were of
analytical grade.
DNA manipulations. The dctA gene from B. subtilis was amplified from
genomic DNA by PCR using Phusion polymerase according to the manufactur-
er’s instructions. For expression in Lactococcus lactis, the PCR products were
cloned into vector pRE-Nlic, essentially as described by Geertsma and Poolman
(9). The pRE-Nlic vector was converted into a plasmid for expression in L. lactis
by the vector-backbone exchange (VBeX) method (9). Vectors were designed in
such a way that an N-terminal decahistidine tag followed by a tobacco etch virus
(TEV) protease cleavage site was added to the protein product. DNA sequencing
by Service XS (Leiden, Netherlands) confirmed that no unwanted mutations had
occurred.
Expression and purification of DctABs. DctABs was expressed in L. lactis
NZ9000 cells (21) grown on M17 medium (Oxoid, Basingstoke, United King-
dom) supplemented with 1% glucose at a constant pH (6.5) and temperature
(30°C). Expression was induced by the addition of nisin A to a 1:5,000 (vol/vol)
dilution of the supernatant from a stationary-phase L. lactis NZ9700 culture at an
optical density at 660 nm of ;1.5 (20). Two hours after induction, cells were
harvested with a Beckman JLA 8.1000 rotor at a relative centrifugal force [RCF]
of 10,000 for 10 min at 4°C and resuspended in 20 mM Tris-HCl (pH 8). DNase
(10 mg/ml), phenylmethylsulfonyl fluoride (PMSF; 200 mM), and MgSO4 (1 mM)
were added, and cells were passed twice through a cell disrupter at 45,000 lb/in2
(Constant Systems Ltd., Daventry, United Kingdom) and cooled at 4°C. Unbro-
ken cells and cell debris were pelleted using a Harrier 18/80 swing-out centrifuge
at an RCF of 5,000 for 25 min at 4°C, and the supernatant was subjected to
ultracentrifugation using a Beckman 50.2 Ti rotor at an RCF of 150,000 for 90
min at 4°C. Membrane pellets were resuspended in 20 mM Tris-HCl (pH 8) and
stored at 280°C. The protein concentrations in the membranes were determined
using Bradford reagent with bovine serum albumin as a standard.
For protein purification (7), membrane vesicles were solubilized in buffer A
(50 mM Tris-HCl [pH 8.0], 300 mM NaCl), containing 15 mM imidazole (pH 8.0)
and 1% n-dodecyl-b-D-maltopyranoside (DDM), at a final protein concentration
of 5 mg/ml. After incubation on ice for 45 min with occasional gentle shaking, the
solution was centrifuged with a Beckman TLA 100.4 rotor at an RCF of 267,000
for 15 min at 4°C. Supernatants were incubated on a rotating platform for 60 min
at 4°C with a nickel-Sepharose slurry (Fast Flow; GE Healthcare) preequili-
brated with buffer A containing 15 mM imidazole, pH 8.0. The mixture was
loaded onto a Bio-Rad Poly-Prep column, and unbound protein was allowed to
flow through. The column was washed with 20 column volumes of buffer A
supplemented with 60 mM imidazole and 0.04% DDM. Protein was eluted from
the column in three fractions of 300, 500, and 500 ml by using buffer A supple-
mented with 500 mM imidazole, pH 8.0, and 0.04% DDM. The second elution
fraction from the affinity chromatography contained most of the purified protein
and was loaded onto a Superdex-200 gel filtration column using 20 mM potas-
sium phosphate, pH 7.0, 150 mM NaCl, and 0.04% DDM as eluents.
Throughout the purification procedure, samples were taken and analyzed by
sodium dodecyl sulfate (SDS)–12.5% polyacrylamide gel electrophoresis. Gels
were stained using Serva Blue G Coomassie brilliant blue.
Fused membrane vesicles. L. lactis membrane vesicles were mixed in a 1:10
(wt/wt) ratio of protein (from the membrane vesicle preparation) to lipid (from
liposomes) with liposomes made from E. coli polar lipids and egg phosphatidyl-
choline (3:1, wt/wt) that had been extruded nine times through a 400-nm-pore-
size polycarbonate filter by using a miniextruder (Hamilton, Bonaduz, Switzer-
land). The mixture was frozen in liquid nitrogen, thawed three times, and
subjected to centrifugation with a Beckman TLA 100.4 rotor at an RCF of
267,000 for 20 min at 4°C. Fused membranes were then resuspended in the
luminal buffer of choice (see the figure legends), again frozen and thawed three
times, and stored in liquid nitrogen. Freezing, thawing, and subsequent extrusion
(see below) were used to load the vesicles with the desired buffer.
Transport assays using fused membrane vesicles. Fused membranes were
thawed, extruded as described above, and centrifuged with a Beckman TLA
100.4 rotor at an RCF of 267,000 for 20 min at 4°C. Membranes were resus-
pended in the internal (luminal) buffer to a total protein concentration of 12.5
mg/ml. In transport assays, fused membrane vesicles were diluted 1003 into 200
ml of external buffer (described in Results) supplemented with [14C]succinate (a
3.1 mM concentration, unless otherwise indicated) and, if applicable, 0.5 mM
valinomycin (3 mM stock solution in ethanol). All assays were performed at
25°C, except when otherwise indicated, and internal and external buffers were
isosmotic. Transport reactions were stopped by the addition of 2 ml of ice-cold
100 mM LiCl, followed by rapid filtration with BA-85 nitrocellulose filters and an
additional wash step with lithium chloride. Levels of radioactivity were deter-
mined by the addition of 2 ml of Emulsifier-Scintillator Plus liquid (PerkinElmer,
Waltham, MA) and analysis with a PerkinElmer Tri-Carb 2800 TR isotope
counter.
RESULTS
Expression and purification of DctABs. Initially we aimed at
the purification of DctABs and reconstitution in proteolipo-
somes. A histidine-tagged variant of the protein was expressed
in the Gram-positive host L. lactis (22). The DctABs protein
was extracted from L. lactis membrane vesicles by solubiliza-
tion using the detergent DDM and purified by nickel affinity
and size exclusion chromatography (Fig. 1A). The protein
eluted at a volume of ;11 ml from the size exclusion column
(Fig. 1B). The trimeric prokaryotic glutamate/aspartate trans-
porters of the DAACS family elute at similar volumes (10, 39,
40), indicating that DctABs is probably also a homotrimer.
However, the size exclusion chromatogram showed that the
protein was prone to aggregation in detergent solution. Static
light-scattering (size exclusion chromatography-multiangle
laser light-scattering [SEC-MALLS]) analysis of DctABs in-
deed showed that the elution peak was not monodisperse, but
the results were consistent with a trimeric oligomeric state of
the protein in the main peak (data not shown). Varying the
buffer composition (by the addition of glycerol or salt) or the
pH (from 6 to 8.5) did not improve the stability of the protein,
nor did the addition of a substrate (succinate) to the buffers
throughout the purification. The chromatogram for DctABs
shown in Fig. 1B was the best obtained.
The DctABs protein from the peak fraction around the elu-
tion volume of 11 ml was used in reconstitution trials. In
addition, DctABs that had been partially purified by only metal
affinity chromatography was also used in reconstitution trials.
All attempts to functionally reconstitute the purified protein
into proteoliposomes failed. Different detergents (maltoside
series and octyl glucoside) and reconstitution protocols (deter-
















































gent removal by rapid dilution [14] and BioBead adsorption
[8]) were tested, but none resulted in functional protein.
DctABs is a proton-coupled succinate transporter. It was
possible that the failure to reconstitute DctABs in an active
form had been caused by instability of the protein in detergent
solution. To avoid the need for solubilization of DctABs by
detergents, in vitro transport assays using membrane vesicles
prepared from L. lactis cells overexpressing DctABs were at-
tempted. We monitored the uptake of radiolabeled succinate
into membrane vesicles in the presence of chemical gradients
for sodium ions and protons and a negative membrane poten-
tial (DmH1, DmNa1, and DC, respectively) (Fig. 2). Rapid succi-
nate transport in membrane vesicles containing DctABs was
observed. Transport was DctA mediated, because no accumu-
FIG. 1. Purification of DctABs. (A) Protein samples from different steps throughout the purification were run on an SDS–12.5% polyacrylamide
gel, which was stained with Coomassie brilliant blue. Lanes: 1, membrane vesicles (10 mg of protein); 2, DDM-soluble fraction; 3, insoluble fraction;
4, flowthrough from the nickel-Sepharose column; 5, wash fraction from the Ni-Sepharose column; 6 to 8, three elution fractions from the
nickel-Sepharose column; and 9, peak fraction (at an elution volume of ;11 ml) from the size exclusion chromatography step. The arrow indicates
DctABs. M, markers; Mw, molecular mass. (B) The peak elution fraction from the nickel-Sepharose column (lane 7) was subjected to size exclusion
chromatography with a Superdex-200 column. The chromatogram is shown.
FIG. 2. Succinate transport by DctABs in membrane vesicles. (A) Membrane vesicles containing DctABs (circles) or ThiT (negative control;
triangles) were loaded with 100 mM K-HEPES (pH 7.5). The vesicles were diluted 100-fold in an isosmotic Na-MES buffer, pH 5.5 (consisting of
;135 mM MES [morpholineethanesulfonic acid] adjusted to pH 5.5 with NaOH), containing 3.1 mM [14C]succinate in the presence (closed
symbols) or absence (open symbols) of 0.5 mM valinomycin. In this way, chemical gradients for protons and sodium ions (DmH1 and DmNa1) were
created. In the presence of valinomycin, an additional K1 diffusion potential, DC (Nernst potential, 2118 mV), was created. (B) Initial
[14C]succinate transport rates in the presence of various gradients. Columns correspond to the presence of gradients as follows: 1, DmH1, DmNa1,
and DC; 2, DmH1 and DC; 3, DmH1 and DmNa1; 4, DmH1; 5, DmNa1 and DC; and 6, negative control. Initial transport rates were calculated from data
for the 15-s time point (see panel A). Data were normalized, and the highest measured rate [47.4 pmol (mg protein z s)21] was set at 100%. Proton
and sodium ion gradients (DmH1 and DmNa1) in the presence or absence of DC were created as described in the legend to panel A. To create DmH1
in the absence of DmNa1, external methylglucamine-MES buffer (pH 5.5) was used instead of Na-MES buffer. Again, the addition of valinomycin
was used to create a K1 diffusion membrane potential (DC) where indicated. To create DmNa1 and DC in the absence of DmH1, Na-HEPES (pH
7.5) was used as the external buffer and valinomycin was present. ThiT-harboring vesicles were used as a control in the presence of all three
gradients. All data are averages of three independent measurements; error bars indicate standard deviations.
















































lation of succinate was observed in membrane vesicles in which
the unrelated thiamine transporter ThiT from L. lactis was
overexpressed (6). To establish which ion gradients were re-
quired for transport, we varied the composition of the external
buffers. Omission of the sodium ion gradient (DmNa1) did not
affect transport rates, but when the pHs on the two sides of the
membrane were equal, transport rates and accumulation levels
were strongly reduced, regardless of the presence of a gradient
of sodium ions. An internal negative membrane potential stim-
ulated succinate transport rates and accumulation levels both
with and without a pH gradient, indicating that transport by
DctABs was electrogenic, with a net positive charge moving in
the same direction as the dicarboxylate substrate.
Succinate transport by DctABs is inhibited by other C4-
dicarboxylates. To determine the substrate specificity of
DctABs, we tested whether the addition of a 50-fold excess of
unlabeled putative substrates inhibited transport of radiola-
beled succinate (Fig. 3). Only the addition of the C4-dicarboxy-
lates succinate, fumarate, malate, and oxaloacetate strongly
inhibited uptake of [14C]succinate into the membrane vesicles.
The addition of maleate and various C3- and C5-dicarboxylates
did not inhibit transport. None of the natural amino acids were
able to inhibit succinate transport. Also, the addition of cyste-
ate, gamma-aminobutyric acid (GABA), orotate, glyoxylate,
and a-ketoglutarate had no effect on succinate uptake. It must
be noted that the results do not exclude the possibility that the
noninhibitory compounds may be low-affinity substrates, be-
cause only 170 mM concentrations were used in the inhibition
assay. However, as discussed below, a counterflow assay
showed that it is very unlikely that the compounds are (low-
affinity) substrates of DctABs.
Fumarate, oxaloacetate, and malate are substrates for
DctABs. The results of the inhibition assay (Fig. 3) demon-
strated that DctABs might transport fumarate, malate, and
oxaloacetate. On the other hand, these compounds could also
be competitive inhibitors that bind to the transporter without
being transported themselves and, thus, block transport of
radiolabeled succinate. To establish whether fumarate, oxalo-
acetate, and malate were indeed transported by DctABs, we
used a counterflow assay. Membrane vesicles were loaded with
1 mM unlabeled (putative) substrate and diluted in the same
buffer containing radiolabeled succinate. If the unlabeled di-
carboxylate was indeed transported, exchange of the internal
(unlabeled) substrate and external (labeled) succinate would
lead to accumulation of [14C]succinate, due to the concentra-
tion gradient across the membrane. In the counterflow exper-
iments, internalization of the radiolabeled substrate was ob-
served when membrane vesicles were loaded with succinate
(demonstrating homologous counterflow) (Fig. 4). Also, the
presence of malate, fumarate, or oxaloacetate in the lumina of
the membrane vesicles resulted in uptake of radiolabeled suc-
cinate into the vesicles. The presence of orotate, citrate, and
maleate in the lumina of the vesicles did not result in the
induction of succinate counterflow by DctABs, nor did the
presence of aspartate, glyoxylate, or a-ketoglutarate (data not
shown). We also did not observe succinate counterflow when
no substrate was added to the internal buffer. Control mem-
branes in which ThiT was expressed instead of DctABs also did
not show counterflow of the radiolabeled substrate, regardless
of the presence of the internal substrate. DctABs thus appears
FIG. 3. Succinate transport by DctABs in membrane vesicles in the
presence of putative transport inhibitors. Transport of [14C]succinate
(3.1 mM) in the presence of DmH1, DmNa1, and DC (2118 mV) was
measured as described in the legend to Fig. 2A. The external buffer
was supplemented with a 50-fold excess of the indicated compounds.
Initial transport rates were determined as described in the legend to
Fig. 2B and normalized with respect to the rate without inhibitors
[100%, corresponding to 37.5 pmol (mg protein z s)21]. Measurements
were performed in quadruplicate, and standard deviations are shown.
FIG. 4. Succinate counterflow by DctABs. Membrane vesicles were
loaded with 50 mM potassium phosphate (pH 7.0) supplemented with
1 mM succinate (closed circles), fumarate (open circles), malate
(closed triangles), oxaloacetate (open triangles), maleate (open
squares), citrate (closed squares), or orotate (closed diamonds) and
diluted 200-fold in external buffer (50 mM potassium phosphate, pH
7.0) supplemented with 3.1 mM [14C]succinate. As a negative control,
membrane vesicles that were not loaded with any substrate (open
diamonds) or vesicles loaded with 1 mM succinate (crosses) in which
ThiT was expressed were used. Measurements were done in triplicate;
error bars indicate standard deviations.
















































to be specific for a narrow set of C4-dicarboxylates. The coun-
terflow assay also showed that aspartate, glyoxylate, a-ketoglu-
tarate, orotate, citrate, and maleate are not low-affinity sub-
strates of DctABs because they were not transported even
though they were present at high (1 mM) concentrations.
pH dependence of DctA. The experimental findings pre-
sented in Fig. 2 indicate that DctABs couples succinate trans-
port to protons and not to sodium ions. This observation cor-
responds with results obtained for DctA of C. glutamicum in a
whole-cell experimental setup (41). To gain more insight into
both the optimal pH for transport by DctA and the protona-
tion state of the transported dicarboxylate, we measured the
pH dependence of succinate transport into membrane vesicles.
Interpretation of the pH dependence of succinate transport by
DctABs is complicated because (i) protons are substrates (co-
transported ions), (ii) the protonation state of the dicarboxy-
late substrates depends on the pH, and (iii) there may be other
(regulatory) sites on the protein which can be protonated and
the protonation state of which may affect activity. We per-
formed three experiments to study the pH dependence of
DctABs by using both net uptake and counterflow assays.
In the first experiment, we varied the external pH (5.5 or 7)
while keeping the internal pH (8) constant. We determined the
apparent Km and the Vmax for succinate transport and found
that the transporter follows Michaelis-Menten kinetics, which
has also been shown previously for other members of the
glutamate transporter family (31, 35). The Vmax for succinate
transport was approximately 3-fold lower at an external pH of
7 [1.4 nmol (mg protein)21 s21] than at pH 5.5 [3.9 nmol (mg
protein)21 s21]. This result is consistent with the protons being
cosubstrates. Although protonation of a pH-sensitive regula-
tory site at the extracellular face of the protein could also
explain the results, we will show below that such regulation is
less likely. The apparent Km values for succinate transport
were identical within the range of error (means 6 standard
deviations, 2.8 6 1.0 mM at pH 5.5 and 2.6 6 1.4 mM at pH 7;
n 5 3). The pKa values for the two carboxylate groups in
succinate are 4.2 and 5.6, respectively. At pH 5.5, ;60% of
succinate is in a protonated state (single or double), whereas at
pH 7 this percentage is only ;4%. The 15-fold decrease in the
concentration of the protonated substrate was not reflected in
the apparent Km values, indicating that the doubly deproto-
nated form of succinate must be recognized by the transporter.
Similar interpretations of apparent Km values at different pHs
have been made to determine the protonation state of the
substrate of a glutamate transporter in L. lactis (26). The con-
centration of divalent anionic succinate is ;2-fold higher at pH
7 than at pH 5.5. The increase was also not reflected in the
apparent Km values. Although this result could indicate that
both protonated and unprotonated forms of succinate were
recognized by DctABs, the experimental error in the determi-
nation of the Km values was too large to accurately measure a
2-fold difference.
In the second experiment, we varied the external pH from 5
to 7 and simultaneously varied the internal pH from 6 to 8, so
that a pH gradient of 1 unit was maintained. Succinate trans-
port rates increased by ;3-fold when the internal pH was
raised from 6 to 8 (Fig. 5). The transport rates increased
despite a reduction in the concentration of the cosubstrate
(protons) on the outside, which as described above, was shown
in the previous experiment to decrease the transport rate when
the internal pH was constant. It is therefore likely that the
release of protons on the inside was rate limiting, with the
stimulating effect of a higher internal pH being dominant over
the inhibitory effect of a higher external pH. An alternative
explanation would be that there is a pH-sensitive regulatory
site at the intracellular face of the protein resulting in higher
activity at alkaline pHs. However, this interpretation would
imply that the pH regulation of the protein on the inside and
that on the outside work in opposite directions, which is un-
likely. The more likely explanation for the observations is that
the measured pH dependence directly indicates proton binding
on the outside and release on the inside.
In the third experiment, the pH dependence of succinate
transport by DctABs during counterflow with identical pHs on
the two sides of the membrane was measured. Maximal succi-
nate counterflow activity was observed at pHs of 6.5 to 7.0 (Fig.
6). At lower pHs and at a pH of 7.5, the rate of exchange was
significantly lower. These results suggest that in addition to the
substrate, protons are exchanged during the counterflow assay.
The observed pH optimum for counterflow activity may thus
be a reflection of the stimulation of transport rates by a com-
promise between (i) high proton concentrations on the outside
and (ii) low concentrations on the inside during the counter-
flow reaction. These results corroborate the interpretation of
the findings from the succinate uptake experiments described
above, from which we concluded that the measured pH depen-
dence of succinate transport directly represents proton binding
on the outside and release on the inside. Exchange of a cou-
pling ion during counterflow has also been observed previ-
ously, e.g., with the neutral amino acid transporter ASCT-1
(44) of the DAACS family. In this case, a sodium ion was
exchanged.
A negative membrane potential stimulates succinate trans-
port by DctA. Succinate transport by DctABs is electrogenic, as
FIG. 5. pH dependence of succinate transport. Membrane vesicles
were loaded with a mixture of 50 mM K-MES and 50 mM K-HEPES
adjusted to a pH of 6, 7, or 8, and the loaded vesicles were diluted in
isosmotic Na-MES–Na-HEPES buffer adjusted to a pH of 5, 6, or 7.
The external buffer contained 3.1 mM [14C]succinate and 0.5 mM
valinomycin.
















































depicted in Fig. 2. To further analyze the effect of the mem-
brane potential on succinate transport by DctABs, the magni-
tude and sign of the membrane potential were varied. Mem-
brane vesicles were loaded with a buffer containing 10 mM
potassium ions. By varying the external concentration of potas-
sium ions, potassium diffusion potentials of different magnitudes
were established in the presence of the potassium-selective iono-
phore valinomycin. In the absence of the ionophore valinomycin,
transport was driven solely by the proton gradient and transport
rates and accumulation levels were the same regardless of the
external potassium ion concentration (data not shown), indicating
that the potassium ion concentration does not affect transport.
Lack of potassium ion dependence has also been observed pre-
viously for other prokaryotic transporters of the DAACS family.
In contrast, eukaryotic glutamate transporters require potassium
ions as countertransported ions (24, 28, 31, 45).
The addition of valinomycin resulted in an increase of the
initial transport rates when the external concentration of po-
tassium was lower than the internal concentration and negative
K1 diffusion potentials were generated (Fig. 7). When K1
concentrations on the two sides of the membrane were equal,
the addition of valinomycin also resulted in an increase in
transport rates. This result indicates that the net positive
charge was translocated inward across the membrane. In the
absence of valinomycin, the translocated charge led to the
buildup of a positive membrane potential, thus impeding fur-
ther transport. By clamping the membrane potential at volt-
ages lower than the (positive) equilibrium potential for succi-
nate-proton symport, such impediment was alleviated.
Temperature optimum and Q10 value. We measured initial
rates of [14C]succinate transport by DctABs at temperatures
between 10 and 45°C (data not shown). The rates increased
when the temperature was raised from 10 up to 40°C. The Q10
value was approximately 1.6 for temperatures between 20 and
40°C, suggesting that significant conformational changes take
place during transport. This finding is consistent with results
obtained previously for GltPh (Q10 of 3.7) (31) and various
other bacterial glutamate transporters (Q10s of ;2.2) (M.
Groeneveld, unpublished data), although the Q10 value for
DctABs is lower than those for the aforementioned proteins.
DISCUSSION
Prokaryotic transporters of the DAACS family can be sub-
divided into three separate classes based on substrate specific-
ity (33): glutamate/aspartate transporters, neutral amino acid
transporters, and transporters for C4-dicarboxylates of the
Krebs cycle. Glutamate/aspartate transporters and the serine/
threonine transporter SstT have been studied in vitro using
membrane vesicles and purified proteins reconstituted into
liposomes, but DctA-type dicarboxylate transporters have been
studied in whole-cell assays only.
In this report, we describe the characterization of DctABs in
membrane vesicles from L. lactis in which DctABs was over-
produced. We observed DctABs-specific succinate transport in
these membranes, and a series of inhibition and counterflow
assays showed that fumarate, malate, and oxaloacetate were
also transported by DctABs. The substrate specificity of DctABs
is narrower than that of other DctA homologues, which have
been reported to transport other compounds such as orotate,
glyoxylate, and a-ketoglutarate (41, 42). None of these sub-
strates were transported by DctABs.
FIG. 6. pH dependence of succinate transport during counterflow.
Membrane vesicles were loaded with 50 mM potassium phosphate,
supplemented with 1 mM unlabeled succinate, at the indicated pHs.
Membrane vesicles were diluted 100-fold in the same external buffer
but supplemented with 3.1 mM [14C]succinate instead of the unlabeled
succinate. Error bars indicate the standard deviations, taken from
three measurements.
FIG. 7. Succinate transport in the presence of membrane poten-
tials of different magnitudes. Membrane vesicles were loaded with 100
mM Na-HEPES buffer (pH 7.5) supplemented with 10 mM KCl. Mem-
brane vesicles were diluted in external buffer consisting of Na-MES,
pH 5.5, and 3.1 mM [14C]succinate supplemented with 0 mM KCl
(closed circles), 2 mM KCl (open circles), 10 mM KCl (closed trian-
gles), or 50 mM KCl (open triangles) in the presence of 0.5 mM
valinomycin. The concentration of Na-MES was adjusted to ensure
that the external and internal solutions were isosmotic. As a control,
succinate transport in membrane vesicles in which ThiT was expressed
was measured with 0 mM KCl in the external buffer (closed squares).
The values of the K1 equilibrium potentials are indicated.
















































We made a homology model of the substrate-binding site of
DctABs by using the crystal structure of GltPh as a template
(data not shown). When the amino acids in GltPh involved in
substrate binding (2) were compared with the corresponding
amino acids in DctABs, only a few differences were found. The
most obvious difference is the replacement of Asp394 from
GltPh by Ser377 in DctABs. In GltPh, Asp394 interacts with the
a-amino group of the substrate aspartate, which is not present
in the dicarboxylate substrates of DctABs. The binding pocket in
GltPh for the two carboxylates of aspartate is strongly conserved in
DctABs. The pH dependence of succinate transport by DctABs
suggested that the doubly deprotonated (divalent anionic) form
of succinate was recognized by the transporter, which would be
consistent with the presence of a conserved binding site for the
two carboxylate groups, because the divalent anionic form of
aspartate is also transported by GltPh (2, 31).
Substrate transport by DctABs was coupled to proton trans-
port (symport) and was not dependent on sodium ions. Succi-
nate transport was stimulated by a negative membrane poten-
tial, indicating that transport was electrogenic. Therefore, at
least three protons must be transported with the divalent anion
succinate. This pattern is in contrast with succinate transport
by the Staphylococcus aureus protein SdcS, a sodium-coupled
C4-dicarboxylate transporter of the divalent anion:Na
1 sym-
porter (DASS) family, which has been characterized using
proteoliposomes containing purified protein. SdcS transports a
doubly deprotonated substrate together with two sodium ions,
resulting in electroneutral transport (13). On the other hand,
transport by eukaryotic homologues of SdcS (members of the
SlC13 subfamily) is electrogenic; three sodium ions are co-
transported with a divalent substrate (25).
Glutamate/aspartate transporters of the DAACS family use
either protons (in the case of GltP from E. coli) or sodium ions
(in the case of GltPh) as coupling ions. Sodium ion binding by
the aspartate transporter GltPh, for which a crystal structure
has been determined, has been studied in detail. By using
thallium ions to replace sodium in the crystals of GltPh, Boud-
ker et al. found two distinct sodium-binding sites in the pro-
tein, in close proximity to the aspartate-binding site (2). We
compared the sodium ion-binding sites in the crystal structure
of GltPh with sites in the homology model of DctABs and found
surprisingly few differences. In the first site, the sodium ion is
coordinated by three backbone carbonyl oxygen atoms and a
carboxylate from Asp405 in GltPh. This aspartate residue is
conserved among human homologues (40), and another acidic
residue (glutamate) is present in the binding site of the sodium-
coupled serine/threonine transporter SstT from E. coli. Proton-
coupled transporters such as DctA or bacterial glutamate
transporters such as GltT from B. stearothermophilus (40) lack
the aspartate residue in the first binding site and contain an
asparagine residue instead. In the second predicted sodium-
binding site, the sodium ion is coordinated by backbone car-
bonyls only (33, 40). The homology model of DctABs does not
allow us to pinpoint the locations of the three proton-binding
sites, but based on tertiary-structure conservation, it seems
likely that the proton-binding sites in DctA are at positions
similar to those of the predicted sodium-binding sites in GltPh
(2). The third proton may bind in an additional ion-binding
site, as predicted by Holley and Kavanaugh (15).
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